Big Pharma Is in a Frenzy to Bring Cannabis-Based Medicines to Market
• Alternetig Pharma is busily applying for -- and has already received -- multiple patents for the medical properties of pot. These include patents for synthetic pot derivatives, cannabinoid agonists like HU-210 and cannabis antagonists such as Rimonabant.
